We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Mylan NV | NASDAQ:MYL | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 15.855 | 15.71 | 15.90 | 0 | 01:00:00 |
From May 2019 to May 2024
Drug makers Valeant Pharmaceuticals International Inc., Actavis PLC and Mylan Inc. have all expressed interest in buying Pfizer Inc.'s branded generics business, but no active discussions are going on at this time, Reuters reported, citing three people close to the matter.
Pfizer is aware of each of the companies' interest but isn't yet ready to entertain a deal as it prepares the groundwork for a potential separation of the generics business, Reuters reported.
Full story at http://www.reuters.com/article/2014/01/14/us-pfizer-valeant-idUSBREA0D0CZ20140114
Write to copydesk@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Mylan NV Chart |
1 Month Mylan NV Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
